JLE

Virologie

MENU

La protéine X du virus de l’hépatite B et son rôle dans le développement du carcinome hépatocellulaire Volume 18, issue 4, Juillet-Août 2014

Figures


  • Figure 1

  • Figure 2

  • Figure 3

  • Figure 4

  • Figure 5
Authors
1 Inserm U845, Équipe pathogenèse des hépatites virales B et immunothérapie, 156, rue de Vaugirard 75015 Paris, France
2 Université Paris Descartes, Sorbonne Paris-Cité, Faculté de médecine Necker, 156, rue de Vaugirard 75015 Paris, France
3 Inserm U1135, CIMI, Équipe infection viral persistante, 91, boulevard de l’Hopital 75013 Paris, France
4 Sorbonne Universités, UPMC Université Paris 06, France
* Tirés à part

Hepatocellular carcinoma (HCC) is the most frequent form of liver cancer worldwide, and represents the third cause of death. While epidemiological studies have clearly established that hepatitis B virus (HBV) infection is a major risk factor for the development of HCC, the molecular mechanisms underlying virally-induced tumourigenesis are not fully understood. The transcriptional regulatory HBx protein has been described as a multifunctional protein exhibiting numerous activities affecting gene transcription, intracellular signal transduction, cell proliferation, apoptosis and DNA repair. While any or all of the multiple activities of HBx could contribute to hepato-carcinogenesis, HBx is not considered as an oncogene. HBx rather acts as a co-factor of carcinogenesis, through the up-regulation of a large number of cellular genes involved in oncogenesis, proliferation, inflammation and immune response. In this review, we will summarize the current knowledge on the mechanisms involving HBx protein in liver carcinogenesis.